Allspring Global Investments
JBIO

Allspring Global Investments’s Jade Biosciences JBIO Stock Holding History

Allspring Global Investments’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-27
Closed -$17K – 2699
2022
Q1 		$17K Sell
27
-4
-13% -$1.55K ﹤0.01% 2947
2021
Q4 		$12K Buy
+31
New +$15.7K ﹤0.01% 2915

Other funds holding JBIO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return

Allspring Global Investments's JBIO Position: Q2 2022 in Review

Allspring Global Investments sold out of Jade Biosciences (JBIO) in Q2 2022, closing a stake of 27 shares — an estimated $17K sold.

Allspring Global Investments first reported a position in JBIO in Q4 2021 and held it in 2 quarters. The position peaked at $17K in Q1 2022. 49 funds tracked by Wall St. Rank hold JBIO as of Q2 2022.

  • Allspring Global Investments reported no remaining Jade Biosciences position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 27 Jade Biosciences shares in Q2 2022, an estimated $17K.
  • Allspring Global Investments first reported a position in Jade Biosciences in Q4 2021 and held it in 2 quarters.
  • Allspring Global Investments's Jade Biosciences position peaked at $17K in Q1 2022.
  • 49 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.